The Effects of Juglone on Cell Proliferation and Insulin- Like Growth Factor I Receptor/Phosphoinositide 3-Kinase/p85 (IGF-IR/PI3K/p85) Signaling Pathway in Pancreatic Cancer
Juglone exerts negative regulatory effects on pancreatic cancer, some of which are likely mediated through the IGF-IR/PI3K/p85 signaling pathway. Therefore, juglone may serve as a potential therapeutic option for the treatment and prevention of the progression of this devastating cancer.
Authors
- Duygu Dursunoğlu (ORCID: https://orcid.org/0000-0003-4414-8659)
Institutions
- Selçuk University (TR)
Publication Details
- Journal
- Journal of Clinical Practice and Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14744/cpr.2025.50464
- Citations
- 1
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81